WHO experts met on Monday to discuss, among other things, whether AstraZeneca’s corona vaccine should be given to people over 65 years of age.
Several countries, including Norway, do not recommend that the AstraZeneca vaccine be given to anyone over the age of 65, due to a lack of evidence of efficacy.
South Africa decided this weekend to stop using the vaccine completely after a study showed that it has little effect against the mutated South African variant of the virus.
For the same reason, the Norwegian Nurses’ Association has asked the National Institute of Public Health (FHI) to make a new assessment of the vaccine, especially considering that health personnel are among those who are first in the vaccine queue.
New recommendation expected
The 15 members of the WHO’s vaccine expert group (Sage) gathered on Monday for an extraordinary meeting to reconsider the advice previously given about the AstraZeneca vaccine.
At the meeting, the manufacturer will give a 25-minute presentation on how safe and effective the vaccine is, as well as present the latest results from tests that have been carried out.
The WHO’s expert group will then make a new recommendation, but it will only happen later this week.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at [email protected]
Be the first to comment on "WHO prepares new assessment of AstraZeneca’s corona vaccine"